Results 101 to 110 of about 131,343 (196)

An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice. [PDF]

, 2019
Chronic or excess glucocorticoid exposure causes lipid disorders such as hypertriglyceridemia and hepatic steatosis. Angptl4 (angiopoietin-like 4), a primary target gene of the glucocorticoid receptor in hepatocytes and adipocytes, is required for ...
Cheang, Rachel T, Chen, Tzu-Chieh, Fitch, Mark D, Gray, Nora E, Hellerstein, Marc K, Kanamaluru, Deepthi, Lee, Justin Y, Lee, Rebecca A, Tan, Jenna H, Tsai, Sam L, Wang, Jen-Chywan, Yiv, Nicholas   +11 more
core  

Sudden Death Due to Association between NAFLD and Cardiovascular Changes in a 37-Year-Old Man: a Case Report

Acta Medica Iranica, 2016
Fatty liver disease (FLD) is the most prevalent form of liver disease worldwide. Overnutrition can induce nonalcoholic fatty liver disease (NAFLD), a spectrum of conditions ranging from simple steatosis [or nonalcoholic fatty liver (NAFL)] to ...
Maryam Ameri, Shahrokh Mehrpisheh, Azadeh Memarian, Payam Balvayeh   +3 more
doaj  

Nonobese nonalcoholic fatty liver disease [PDF]

Clinical Liver Disease, 2017
Elizabeth, Aby, Sammy, Saab
openaire   +2 more sources

PSpa Treatment of Nonalcoholic Fatty Liver Disease in Patients with Metabolic Syndrome with Drinking Mineral Water of Essentuki Type Applications

Медицинский вестник Юга России, 2012
Purpose: To study the efficiency of spa therapy using drinking mineral waters Essentuki №4 and Essentuki-New in treatment of patients with nonalcoholic fatty liver disease.
T. E. Fedorova, N. V. Efimenko, M. H. Ortabaeva, V. P. Demchenko, N. A. Muhotin   +4 more
doaj  

Characterization of the gut virome in patients with nonalcoholic fatty liver disease. [PDF]

J Transl Med
Wang L, Wang L, Liu M, Yuan Q, Cheng L, Chen H, Mao S, Li S, Yan Q, Xing G, Zheng N.   +10 more
europepmc   +1 more source

Exploring the pathogenesis of nonalcoholic fatty liver disease complicated by atherosclerosis via bioinformatics. [PDF]

Medicine (Baltimore)
Yan R, Li P, Song J, Qiang Y, Zhai G.
europepmc   +1 more source

Pediatric nonalcoholic fatty liver disease [PDF]

Clinical Liver Disease, 2018
T, Mitsinikos, R, Kohli
openaire   +2 more sources

The Therapeutic Effect and Mechanism of <i>Lactobacillus gardneri</i> on Nonalcoholic Fatty Liver Disease. [PDF]

J Microbiol Biotechnol
Zhu K, Xiang J, Lu F, Wang J, Zhang Y, Feng H, Xiang X.   +6 more
europepmc   +1 more source

Association Between Nonalcoholic Fatty Liver Disease and the Dietary Index for Gut Microbiota: A Cross-Sectional Study. [PDF]

Food Sci Nutr
Yang Q, Cai X, Li S, Xiao Z.
europepmc   +1 more source

Enzyme-Activated Self-Assembling Peptides Mimicking Adiponectin Multimers for Nonalcoholic Fatty Liver Disease Therapy. [PDF]

ACS Cent Sci
Li Z, Duan S, Zhu Z, Han H, Qin N, Ji Q, Yuan D, Shi J.   +7 more
europepmc   +1 more source